Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 845 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$9.29B
Operating Margin
3.61%
TTM Avg
7.20%
3Y Avg
11.56%
5Y Avg
12.63%
Market Cap
$9.61B
Operating Margin
44.93%
TTM Avg
32.03%
3Y Avg
-38.09%
5Y Avg
-25.39%
Market Cap
$9.65B
Operating Margin
5.69%
TTM Avg
5.75%
3Y Avg
6.18%
5Y Avg
6.20%
Market Cap
$9.00B
Operating Margin
-24.28%
TTM Avg
-49.63%
3Y Avg
-136.06%
5Y Avg
-90.71%
Market Cap
$8.98B
Operating Margin
3.61%
TTM Avg
7.20%
3Y Avg
11.56%
5Y Avg
12.63%
Market Cap
$10.01B
Operating Margin
9.08%
TTM Avg
10.48%
3Y Avg
12.70%
5Y Avg
14.08%
Market Cap
$10.05B
Operating Margin
8.32%
TTM Avg
1.27%
3Y Avg
9.53%
5Y Avg
14.21%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.34B | 0.00% | 0.00% | 0.00% | 0.00% |
| Insulet Corp. (PODD)vs › | $9.38B | 16.89% | 16.20% | 12.06% | 10.90% |
| Bruker Corporation (BRKR)vs › | $9.29B | 3.61% | 7.20% | 11.56% | 12.63% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.61B | 44.93% | 32.03% | -38.09% | -25.39% |
| Henry Schein, Inc. (HSIC)vs › | $9.65B | 5.69% | 5.75% | 6.18% | 6.20% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.00B | -24.28% | -49.63% | -136.06% | -90.71% |
| Bruker Corporation (BRKRP)vs › | $8.98B | 3.61% | 7.20% | 11.56% | 12.63% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.01B | 9.08% | 10.48% | 12.70% | 14.08% |
| Repligen Corporation (RGEN)vs › | $10.05B | 8.32% | 1.27% | 9.53% | 14.21% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.79B | -343.63% | -142.72% | -233.94% | -270.19% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
